327 related articles for article (PubMed ID: 19725579)
1. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
2. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
[TBL] [Abstract][Full Text] [Related]
3. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
[TBL] [Abstract][Full Text] [Related]
4. Antiviral efficacy upon administration of a HepDirect prodrug of 2'-C-methylcytidine to hepatitis C virus-infected chimpanzees.
Carroll SS; Koeplinger K; Vavrek M; Zhang NR; Handt L; MacCoss M; Olsen DB; Reddy KR; Sun Z; van Poelje PD; Fujitaki JM; Boyer SH; Linemeyer DL; Hecker SJ; Erion MD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3854-60. PubMed ID: 21628542
[TBL] [Abstract][Full Text] [Related]
5. Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
Hecker SJ; Reddy KR; van Poelje PD; Sun Z; Huang W; Varkhedkar V; Reddy MV; Fujitaki JM; Olsen DB; Koeplinger KA; Boyer SH; Linemeyer DL; MacCoss M; Erion MD
J Med Chem; 2007 Aug; 50(16):3891-6. PubMed ID: 17636948
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
7. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
McGuigan C; Perrone P; Madela K; Neyts J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
[TBL] [Abstract][Full Text] [Related]
8. The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.
McGuigan C; Daverio F; Nájera I; Martin JA; Klumpp K; Smith DB
Bioorg Med Chem Lett; 2009 Jun; 19(11):3122-4. PubMed ID: 19398331
[TBL] [Abstract][Full Text] [Related]
9. QSAR models for phosphoramidate prodrugs of 2'-methylcytidine as inhibitors of hepatitis C virus based on PSO boosting.
Cheng Z; Zhang Y; Zhou C
Chem Biol Drug Des; 2011 Dec; 78(6):948-59. PubMed ID: 21895985
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2'-C-methyl-cytidine to its 5'-monophosphate metabolite.
Golitsina NL; Danehy FT; Fellows R; Cretton-Scott E; Standring DN
Antiviral Res; 2010 Mar; 85(3):470-81. PubMed ID: 19883694
[TBL] [Abstract][Full Text] [Related]
11. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
[TBL] [Abstract][Full Text] [Related]
12. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel phosphoramidate prodrugs of 2'-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase.
Donghi M; Attenni B; Gardelli C; Marco AD; Fiore F; Giuliano C; Laufer R; Leone JF; Pucci V; Rowley M; Narjes F
Bioorg Med Chem Lett; 2009 Mar; 19(5):1392-5. PubMed ID: 19181520
[TBL] [Abstract][Full Text] [Related]
14. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786
[TBL] [Abstract][Full Text] [Related]
15. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
[TBL] [Abstract][Full Text] [Related]
16. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of 1'-C-cyano-2'-fluoro-2'-C-methyl pyrimidine nucleosides as HCV polymerase inhibitors.
Kirschberg TA; Mish MR; Zhang L; Squires NH; Wang KY; Cho A; Feng JY; Fenaux M; Babusis D; Park Y; Ray AS; Kim CU
Bioorg Med Chem Lett; 2015 Mar; 25(5):1040-3. PubMed ID: 25650256
[TBL] [Abstract][Full Text] [Related]
18. Phosphoramidate prodrugs deliver with potency against hepatitis C virus.
Mehellou Y
ChemMedChem; 2010 Nov; 5(11):1841-2. PubMed ID: 20865770
[No Abstract] [Full Text] [Related]
19. Aspartic acid based nucleoside phosphoramidate prodrugs as potent inhibitors of hepatitis C virus replication.
Maiti M; Maiti M; Rozenski J; De Jonghe S; Herdewijn P
Org Biomol Chem; 2015 May; 13(18):5158-74. PubMed ID: 25849139
[TBL] [Abstract][Full Text] [Related]
20. Discovery of β-d-2'-deoxy-2'-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication.
Pinho P; Kalayanov G; Westerlind H; Rosenquist Å; Wähling H; Sund C; Almeida M; Ayesa S; Tejbrant J; Targett-Adams P; Eneroth A; Lindqvist A
Bioorg Med Chem Lett; 2017 Aug; 27(15):3468-3471. PubMed ID: 28622881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
